Brian Adams - 31 Dec 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
General Counsel
Signature
/s/ Brian Adams
Issuer symbol
RLAY
Transactions as of
31 Dec 2021
Net transactions value
+$17,174
Form type
4
Filing time
07 Jan 2022, 16:15:26 UTC
Previous filing
27 Dec 2021
Next filing
31 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Award $17,174 +658 +2.6% $26.10 25,647 31 Dec 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.
F2 In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021.
F3 Includes 12,895 shares underlying RSUs.